Robot model
Aletta
Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion,…
- Manufacturer
- Vitestro
- Form factor
- service
- Maturity
- research
- Lifecycle
- active
- Website
- vitestro.com ↗
The verified answer
As of Aug 2026, DEPLOY verifies Aletta, a service by Vitestro (research). 1 source back the record.
Overview
Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.
Verified vs. claimed
- Maturity stage
- research(Lab-stage only; no commercial or public deployment reported.)
- Sources on file
- View all sources →
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Key facts
Autonomy level
Sensor suite
First-stick success
Regulatory approval
Specs
Class
Success
Data & sources
Web sources
1
1 source backing this record.View all →
Autonomy: verified vs claimed
- What it actually does
- Autonomous
Pricing
No verified price is on record for Aletta. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Aletta on the deployment map
View the global mapWhere Aletta is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 24, 2026
Added to the verified registry
Safety record
No incidents on record for Aletta.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
What is Aletta?
How much does Aletta cost?
Is Aletta actually deployed in the real world?
Who makes Aletta?
Can you buy Aletta?
What are alternatives to Aletta?
How does Aletta compare to Tally?
Is Aletta a top service?
What is Aletta's maturity stage?
Where is Aletta deployed?
Is Aletta safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-22
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-22
Maturity + lifecycle
Maturity stage: research
Lifecycle: active
Architectural position
Cohort: service
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Aletta.Recent coverage
Aletta in third-party press
In the press
Recent coverage mentioning Aletta from third-party publications. Automatically surfaced; not part of the verified registry record.
Vitestro raises 0M to ready blood collection robot for US launch
Vitestro raised 0M in oversubscribed Series B to advance autonomous robotic phlebotomy. EU CE mark gained in 2024, launched in EU healthcare settings March 2025. Preparing US…
Vitestro Unveils Aletta: The World's First Autonomous Robotic Phlebotomy Device
Vitestro unveiled Aletta, the world's first autonomous robotic phlebotomy device (ARPD). Raised 0M Series B for commercial readiness.
Machine-readable surfaces
- Markdown mirror: /models/vitestro-aletta.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/507fabb9-64cd-4561-9d52-4f536c2aaf09
- Revision history: /models/vitestro-aletta/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Subscribe to our YouTube channel for free here: https://sc.mp/subscribe-youtube A hospital in eastern China’s Zhejiang province showcased using robots to aid
Not all robots walk on two legs. Aletta is a robot that makes drawing blood completely automated. We live in the future
Patients fear needles, nurses struggle with finding veins, and we are all skeptical about robots doing a human’s job. But still, automation seems like the per
Vitestro maakt autonome bloedafname apparaten. In deze video zie jij mijn eerste indruk van het apparaat, een interview met de oprichters Toon Overbeeke en Bria
Vitestro’s Aletta system is redefining clinical workflows as the world’s first Autonomous Robotic Phlebotomy Device (ARPD). Using near‑infrared imaging and Dopp
Jaarlijks worden in Nederland tientallen miljoenen bloedafnames gedaan. Een handeling die steeds vaker onder druk staat door personeelstekorten in de zorg. Het
Have you ever wondered what goes on behind the scenes in famous movies? This short is about some fun and exciting moments from an iconic movie 🎬 Alita: Batt
With a 94.3% success rate, this AI-powered tech by Beijing Magicnurse is redefining the future of healthcare. 🚀🩺 Would you let a robot draw your blood? #heal
In Alita: Battle Angel (2019) ⚙️🦾, one of the most electrifying turning points comes when Alita is struck during her clash with the Centurion. That single blow
Reality vs attention
Aletta draws attention at the 61st percentile but verifies reality at the insufficient-data level among service robots.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026